282 related articles for article (PubMed ID: 16869345)
1. Management of high-risk patients on non-steroidal anti-inflammatory drugs or aspirin.
Chan FK
Drugs; 2006; 66 Suppl 1():23-8; discussion 29-33. PubMed ID: 16869345
[TBL] [Abstract][Full Text] [Related]
2. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment.
Chan FK; Graham DY
Aliment Pharmacol Ther; 2004 May; 19(10):1051-61. PubMed ID: 15142194
[TBL] [Abstract][Full Text] [Related]
3. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
Limmer S; Ittel TH; Wietholtz H
Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
[TBL] [Abstract][Full Text] [Related]
4. NSAID-induced gastrointestinal damage: current clinical management and recommendations for prevention.
Lanas A; Ferrandez A
Chin J Dig Dis; 2006; 7(3):127-33. PubMed ID: 16808792
[TBL] [Abstract][Full Text] [Related]
5. Role of Helicobacter pylori eradication in aspirin or non-steroidal anti-inflammatory drug users.
Papatheodoridis GV; Archimandritis AJ
World J Gastroenterol; 2005 Jul; 11(25):3811-6. PubMed ID: 15991274
[TBL] [Abstract][Full Text] [Related]
6. Interaction or relationship between Helicobacter pylori and non-steroidal anti-inflammatory drugs in upper gastrointestinal diseases.
Ji KY; Hu FL
World J Gastroenterol; 2006 Jun; 12(24):3789-92. PubMed ID: 16804960
[TBL] [Abstract][Full Text] [Related]
7. Strategies to reduce the GI risks of antiplatelet therapy.
Scheiman JM
Rev Cardiovasc Med; 2005; 6 Suppl 4():S23-31. PubMed ID: 17710073
[TBL] [Abstract][Full Text] [Related]
8. Management of low-dose aspirin and clopidogrel in clinical practice: a gastrointestinal perspective.
Lanas A; Gargallo CJ
J Gastroenterol; 2015 Jun; 50(6):626-37. PubMed ID: 25595209
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for gastrointestinal bleeding associated with low-dose aspirin.
Valkhoff VE; Sturkenboom MC; Kuipers EJ
Best Pract Res Clin Gastroenterol; 2012 Apr; 26(2):125-40. PubMed ID: 22542151
[TBL] [Abstract][Full Text] [Related]
10. Strategies to optimize treatment with NSAIDs in patients at risk for gastrointestinal and cardiovascular adverse events.
Scheiman JM; Hindley CE
Clin Ther; 2010 Apr; 32(4):667-77. PubMed ID: 20435236
[TBL] [Abstract][Full Text] [Related]
11. Unmet needs in non-steroidal anti-inflammatory drug-induced upper gastrointestinal diseases.
Scheiman JM
Drugs; 2006; 66 Suppl 1():15-21; discussion 29-33. PubMed ID: 16869344
[TBL] [Abstract][Full Text] [Related]
12. Low-dose aspirin and upper gastrointestinal damage: epidemiology, prevention and treatment.
Lanas A; Scheiman J
Curr Med Res Opin; 2007 Jan; 23(1):163-73. PubMed ID: 17257477
[TBL] [Abstract][Full Text] [Related]
13. Bleeding peptic ulcer in the elderly: risk factors and prevention strategies.
Zullo A; Hassan C; Campo SM; Morini S
Drugs Aging; 2007; 24(10):815-28. PubMed ID: 17896831
[TBL] [Abstract][Full Text] [Related]
14. The use of proton pump inhibitors in treating and preventing NSAID-induced mucosal damage.
Scheiman JM
Arthritis Res Ther; 2013; 15 Suppl 3(Suppl 3):S5. PubMed ID: 24267413
[TBL] [Abstract][Full Text] [Related]
15. [Current clinical practice among German Internists regarding the prophylaxis of gastroduodenal ulcers associated with NSAIDs, aspirin and Helicobacter pylori].
Schneider AR; Armbruster S; Mann J; von Römer W; Schuster T; Schepp W
Z Gastroenterol; 2012 Nov; 50(11):1156-60. PubMed ID: 23150107
[TBL] [Abstract][Full Text] [Related]
16. Management of NSAID-induced gastrointestinal toxicity: focus on proton pump inhibitors.
Lazzaroni M; Porro GB
Drugs; 2009; 69(1):51-69. PubMed ID: 19192936
[TBL] [Abstract][Full Text] [Related]
17. Prevention of anti-inflammatory drug-induced gastrointestinal damage: benefits and risks of therapeutic strategies.
Lanas A; Hunt R
Ann Med; 2006; 38(6):415-28. PubMed ID: 17008305
[TBL] [Abstract][Full Text] [Related]
18. Reducing NSAID-induced gastrointestinal complications.
Drug Ther Bull; 2011 Feb; 49(2):18-21; quiz i-ii. PubMed ID: 21304164
[TBL] [Abstract][Full Text] [Related]
19. Non-steroidal anti-inflammatory drug toxicity in the upper gastrointestinal tract.
Sung J; Russell RI; Nyeomans ; Chan FK; Chen S; Fock K; Goh KL; Kullavanijaya P; Kimura K; Lau C; Louw J; Sollano J; Triadiafalopulos G; Xiao S; Brooks P
J Gastroenterol Hepatol; 2000 Oct; 15 Suppl():G58-68. PubMed ID: 11100995
[TBL] [Abstract][Full Text] [Related]
20. Management of NSAID-associated peptic ulcer disease.
Melcarne L; García-Iglesias P; Calvet X
Expert Rev Gastroenterol Hepatol; 2016 Jun; 10(6):723-33. PubMed ID: 26775657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
